about
Evaluation of cDNA microarray data by multiple clones mapping to the same transcript.Reproducibility and concordance of differential DNA methylation and gene expression in cancer.Distinct functional patterns of gene promoter hypomethylation and hypermethylation in cancer genomesAn integrated approach to uncover driver genes in breast cancer methylation genomes.Genes dysregulated to different extent or oppositely in estrogen receptor-positive and estrogen receptor-negative breast cancers.Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.REC8 is a novel tumor suppressor gene epigenetically robustly targeted by the PI3K pathway in thyroid cancer.Separate enrichment analysis of pathways for up- and downregulated genes.Epigenetically upregulated WIPF1 plays a major role in BRAF V600E-promoted papillary thyroid cancer aggressiveness.The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer.A six-genotype genetic prognostic model for papillary thyroid cancer.Viewing cancer genes from co-evolving gene modules.Rank-based predictors for response and prognosis of neoadjuvant taxane-anthracycline-based chemotherapy in breast cancer.BRAF V600E Mutation-Assisted Risk Stratification of Solitary Intrathyroidal Papillary Thyroid Cancer for Precision Treatment.Patient Age-Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer.Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control.[Identifying candidate cancer genes based on co-evolving gene modules].BRAF V600E Confers Male Sex Disease-Specific Mortality Risk in Patients With Papillary Thyroid CancerReply to M. Melo et alResponse
P50
Q33498066-30A6E8F7-864C-4E58-B027-2F1076987333Q34123835-4785FF35-A721-4396-B652-1BC05F7F1FB6Q34412798-6716CEA0-D5D6-478F-906E-0ADA35165F70Q34665735-CFB00D4F-0F82-44D9-AEB2-C4BC2C9B6EE5Q34854816-CC1A615F-BB51-4D84-9284-A13A587D534EQ36431628-4C78A2FB-3F86-4846-865F-CD922F9F9AC2Q36629559-CF17A1FD-F894-4874-8F60-2149F1F96028Q37507799-208CDCA4-5190-4C55-9BCB-FE84C6B8BBDBQ37702380-1112060F-B8F2-4AA0-995F-899277D2F1F0Q38743211-0F7DFC35-D84B-41BC-BBAD-2C896F74C8EFQ39163637-F59D2E37-0D44-4B6B-ACC5-E64F5CBEB171Q43153666-957A7F44-6650-4981-8FA9-45F176D124C3Q44283854-E387FAFF-3C85-4F81-97EF-FA611E25BB25Q49808093-D8FF7841-0E78-4343-B828-80886C1C1488Q50146629-8C2846E6-A04C-441D-BC78-AB7144A4407DQ51608397-370A1B15-6849-460B-A322-8CAE24B56855Q52602304-23D8D81F-A883-42C9-89B8-DEA634E3F14FQ58802686-D0F8A678-F0C3-4728-91E5-33DEFEB8F131Q88146389-F71B4352-2812-4820-A519-B98B1AE13208Q89388122-2084633B-B0A0-43CD-AE96-7522D81D3830
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Xiaopei Shen
@ast
Xiaopei Shen
@en
Xiaopei Shen
@es
Xiaopei Shen
@nl
Xiaopei Shen
@sl
type
label
Xiaopei Shen
@ast
Xiaopei Shen
@en
Xiaopei Shen
@es
Xiaopei Shen
@nl
Xiaopei Shen
@sl
prefLabel
Xiaopei Shen
@ast
Xiaopei Shen
@en
Xiaopei Shen
@es
Xiaopei Shen
@nl
Xiaopei Shen
@sl
P106
P31
P496
0000-0002-0004-4228